Compare AZTA & LMRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AZTA | LMRI |
|---|---|---|
| Founded | 1978 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 753.7M |
| IPO Year | 1996 | N/A |
| Metric | AZTA | LMRI |
|---|---|---|
| Price | $24.31 | $9.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $40.60 | $20.75 |
| AVG Volume (30 Days) | 862.2K | ★ 1.1M |
| Earning Date | 05-06-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.52 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $593,821,000.00 | N/A |
| Revenue This Year | $6.99 | $6.54 |
| Revenue Next Year | $5.98 | $5.60 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $19.87 | $7.23 |
| 52 Week High | $41.73 | $19.45 |
| Indicator | AZTA | LMRI |
|---|---|---|
| Relative Strength Index (RSI) | 56.05 | 38.52 |
| Support Level | $19.87 | $7.23 |
| Resistance Level | $32.32 | $16.38 |
| Average True Range (ATR) | 1.22 | 0.78 |
| MACD | 0.66 | 0.19 |
| Stochastic Oscillator | 81.25 | 61.22 |
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities including MRIs, CT scans, PET scans, X-rays, ultrasounds, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated from the Outpatient segment, which generates revenue by performing imaging studies and providing radiologists' interpretations of those studies.